Medical Oncologist
Scientific director at Sociedad de Oncología y Hematología del Cesar, Valledupar, Colombia. Chief of Genitourinary Unit and Clinical Research Unit. Medical Oncologist at Clínica Portoazul, Barranquilla, Colombia. I completed medical school at Universidad del Norte, Barranquilla Colombia. Medical oncologist from University Hospital 12 de Octubre in Madrid, Genitourinary Fellow in the GU unit at University Hospital 12 de Octubre. Master in molecular oncology from Centro de estudios biosanitarios, CNIIO, ESO. Founder of Grupo de Oncología Genitourinaria de Colombia. Member of SEOM, ACHO and LACOG-GU. I focus my practice on patients with prostate, bladder, kidney and testicular cancer.
Astellas, AstraZeneca, BMS, Dr Reddys, Roche, Janssen, Lilly, MSD, Novartis and Technofarma.
Episode 2: Presidential Sessions
Episode 1
COR2ED brings you an update on a selection of late-breaking abstracts presented in the Presidential Symposia at ESMO 2022.
Dr. Ray Manneh Kopp discusses treatment strategies for non-metastatic castration-resistant prostate cancer (nmCRPC) and how to individualise them to the patient.
Dr Ray Manneh Kopp takes a look at the highlights of 2020 from GU CONNECT.